Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials

Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials

Lifen Qiao,1,2,* Jin Wang,2,3,* Guoxian Long,2,4 Yueqiang Jiang1,5 1Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA; 3Department of Emergency, 4Department...

Full description

Bibliographic Details
Main Authors: Qiao L, Wang J, Long G, Jiang Y
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:OncoTargets and Therapy
Subjects:
TKI EGFR chemotherapy lung cancer meta analysis
Online Access:https://www.dovepress.com/sequential-treatment-of-tyrosine-kinase-inhibitor-and-platinum-based-d-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/sequential-treatment-of-tyrosine-kinase-inhibitor-and-platinum-based-d-peer-reviewed-article-OTT

Similar Items